ALMAVIVA SANTÉ acquired by WREN HOUSE

Livingbridge has announced the acquisition of a stake in Everlight Radiology, a world-renowned teleradiology provider, from Intermediate Capital Group (ICG), a global alternative asset manager. This secondary LBO transaction provides the technology-enabled healthcare platform with a new premier institutional sponsor to back its next international growth chapter.

Colosseum Dental Group (CDG), a subsidiary of the Swiss-based Jacobs Holding, has successfully entered into a definitive agreement to acquire 100% of Curaeos. This transaction represents a transformative milestone in the group’s expansion strategy, creating the premier global dental services platform with approximately 800 clinics and over 13,000 professionals. The strategic rationale for the acquisition centers on the high degree of geographical complementarity between the two organizations, providing the group with immediate entry into the Belgian and Dutch markets while significantly densifying its existing leadership positions in Denmark, Italy, and Germany

The acquisition of Blikk Group by EQT Infrastructure, occurring simultaneously with the buyout of Meine Radiologie Holding from Triton, is a landmark consolidation in the German healthcare services market. This dual-track transaction was designed specifically to merge the two entities into a unified, market-leading radiology chain, later rebranded as Evidia. The strategic rationale is centered on achieving massive industrial scale in a fragmented and capital-intensive sector. By combining Blikk’s 30 locations with Meine Radiologie’s network, EQT creates a platform capable of servicing millions of patients with standardized high-quality care

The acquisition of Meine Radiologie Holding by EQT Infrastructure from Triton is a cornerstone transaction in the consolidation of the German outpatient imaging market. Occurring simultaneously with EQT’s acquisition of the Blikk Group from DBAG, the primary rationale for the deal is the merger of these two established entities into a single, market-leading radiology platform. This strategic combination aims to create a dominant player with significant scale in Germany, later rebranded to operate as part of the Evidia group

A consortium led by Goldman Sachs Asset Management and OMERS Infrastructure acquired amedes from Antin Infrastructure Partners. The transaction valued roughly doubling its value since Antin's entry in 2015. The deal aims to support amedes' continued growth through digitalization and further consolidation of the European lab market.

Cerba HealthCare won a highly competitive auction process managed by Goldman Sachs and JP Morgan to acquire Lifebrain from Investindustrial. The transaction marks Cerba's entry as a major player in the Italian market, significantly expanding its European footprint. The acquisition follows a period of rapid growth for the target, which doubled its profitability between 2019 and 2021, partly driven by a high volume of pandemic-related testing. The deal received backing from Cerba's new majority shareholder, EQT, alongside long-term partners

Infratil acquired a majority stake in Pacific Radiology from its existing doctor shareholders. The remaining equity continues to be held by the group's doctors and management, maintaining a strong clinical alignment. The acquisition was funded through Infratil's committed acquisition bridge facility and was a key part of its strategy to build a trans-Tasman healthcare platform, following its acquisition of Qscan in Australia the previous year.

DomusVi completed a major capital reorganization, described as a "jumbo-LBO". This transaction allowed founder Yves Journel to increase his ownership from 30% to 49%, while ICG remains a key controlling partner. The group's management team also participated in the round, investing approximately €50 million for a 2% stake. The deal was financed through a robust structure including €1.6 billion in portable senior debt (representing 6.3x EBITDA) and a €400 million PIK (Payment-in-Kind) line provided by ICG

SimonMed Imaging has entered into a strategic partnership with American Securities, a leading US private equity firm, as part of a growth investment aimed at supporting the company's next phase of expansion. Following the transaction, American Securities has become a shareholder of SimonMed alongside the company's founder and CEO, Dr. John Simon, who retains a central role in the company's governance and strategic direction. This partnership comes at a time of significant growth in the US outpatient medical imaging market, driven by the increasing shift of diagnostic exams from hospitals to specialized centers offering lower-cost services

EQT entered into exclusive negotiations to acquire Cerba HealthCare from Partners Group. The transaction values the group at EUR4.5 billion, significantly higher than initial market estimates (EUR3bn). PSP Investments, a shareholder for four years, realized a partial cash-out but reinvested to remain a key minority partner alongside EQT and the 400 biologist-managers. The deal was financed with a massive EUR2.5 billion Senior Debt package (Term Loan B).